Found 43 matching trials
A Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK Studies
PHASE1This will be a randomized, open-label, single dose, 4-period, period balanc...
Location
GSK Investigational Site
Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2)
NAThe purpose of this study is to see if salsalate, an Nuclear factor-kappaB ...
Location
Grady Memorial Hospital
Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg
PHASE1The purpose of this study is to compare the pharmacokinetic characteristics...
Location
Kyungpook National University Hospital Clinical Trial Center
Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition
PHASE1This is a randomized, open Label, balanced, two-treatment, two-period, two-...
Location
Accutest Research Lab (I) Pvt. Ltd.
Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension
PHASE2Patients with hepatic cirrhosis and previous variceal bleeding will be rand...
Location
Universidade Federal do Rio de Janeiro
Carvedilol for Pre-primary Prophylaxis of Esophageal Varices in Cirrhosis
NAPatients of cirrhosis aged 18 to 75 years who have no esophageal varices wi...
Location
Institute of Liver & Biliary Sciences (ILBS)
Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg
PHASE1The objective of this study was to investigate the bioequivalence of Mylan'...
Location
PRACS Institute, Ltd.
A Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis
NAThis study will include patients with severe degenerative aortic stenosis (...
Location
Renji Hospital,Shanghai
Carvedilol Versus Placebo for Treatment in Post Traumatic Stress Disorder (PTSD)
PHASE2The investigators hypothesize that carvedilol, at less then therapeutic dos...
Location
Artemis Institute for Clinical Research
TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension
PHASE2In China, the majority of hepatocellular carcinoma (HCC) cases stem from ch...
Location
Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Department of Hepatobiliary and Pancreatic Oncology